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 Abstract: Anacardium occidentale Linn. (A. occidentale L.) leaves possess bioactive 
polyphenols which are associated with antidiabetic potency for the management of type 2 
diabetes mellitus (T2DM). In this study, free, soluble ester, and insoluble-bound phenolic 
fractions from young and mature leaves of A. occidentale L. were extracted. 
Subsequently, all fractions were investigated for their inhibitory effect on α-amylase and 
dipeptidyl peptidase IV (DPPIV) activities. Both free (72.45 ± 3.6%) and soluble ester 
(83.40 ± 4.7%) phenolic fractions in the mature leaves extracts had significantly 
demonstrated greater α-amylase inhibitors than the young leaves. Likewise, soluble ester 
(4.09 ± 0.34 µg/mL) and insoluble-bound (4.87 ± 0.32 µg/mL) phenolic fractions in the 
mature leaves extracts were significantly more effective in inhibiting DPPIV than the 
young leaves. As for fractions comparison, insoluble-bound derived from the young leaves 
extract was a more potent α-amylase inhibitor than free and soluble ester phenolic 
fractions (p < 0.0001). Besides, soluble ester and insoluble-bound phenolic fractions 
showed a stronger inhibitor of DPPIV than the free phenolic (p < 0.001), irrespective of 
the maturity of the leaves. In conclusion, this study showed that A. occidentale L. extracts 
possessed antidiabetic properties, which may potentially be used as an alternative 
treatment for T2DM management. 
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■ INTRODUCTION 
Diabetes mellitus is one of the major health 
problems that affect millions of people worldwide. It is 
projected that 642 million people aged 20–79 years 
around the globe will suffer from diabetes by 2040 [1]. In 
Malaysia, since the first National Health Morbidity 
Survey (NHMS I) until recent NHMS V, the prevalence of 
diabetes mellitus among the adult population has 
markedly increased from 6.3% in 1986, 8.2% in 1996, 
11.6% in 2006 and 15.2% in 2011 to 17.5% in 2015 [2-3]. 
Besides, diabetes also becomes one of the leading causes 
of death globally [1]. In 2012, it was reported that diabetes 
had caused 1.5 million (2.7%) deaths [4]. 
The management of diabetes involves continuous 
medical care with multifactorial risk reduction strategies, 
including lifestyle modifications and treatments with 
synthetic hypoglycemic drugs. Nevertheless, it is 
estimated that 70–80% of the world population still 
relies on traditional herbal medicine to meet their 
primary health care needs, including treatments for 
diabetes, especially in rural areas of developing nations 
[5]. For example, plants such as Aloe vera, Andrographis 
paniculata, Centella asiatica, Curcuma longa, and 
Anacardium occidentale have been demonstrated to 
possess antidiabetic properties [6-8], owing to the 
presence of bioactive compounds such as carotenoids 
and polyphenols that act as antidiabetic agents [9]. 
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In the carbohydrate metabolism, polyphenols such 
as phenolic acids, flavonoids, and tannins play a role in 
inhibiting α-amylase, a glycoside hydrolase enzyme that, 
if attenuated can slow down the breakdown of long chain 
carbohydrates to glucose, thus preventing a sudden rise in 
postprandial blood glucose levels [10-12]. 
Polyphenols are also able to regulate postprandial 
glucose levels through the inhibition of dipeptidyl 
peptidase IV (DPPIV), a serine protease that localizes on 
the cell surface of various tissues, including the small 
intestine [13]. By inhibiting DPPIV, it prevents the rapid 
degradation of incretins such as glucagon-like peptide 1 
(GLP-1) and gastric inhibitory peptide (GIP) that play a 
vital role in blood glucose control. GLP-1 and GIP actions 
include stimulating insulin secretion, lowering glucagon 
concentration and slowing gastric emptying [14-15]. 
Anacardium occidentale Linn. (A. occidentale L.) or 
commonly known as cashew tree, is a popular tropical 
plant among various ethnics in Malaysia for its leaves, 
shoots, the cashew seed, and the cashew apple. Its shoots 
or young leaves are especially one of the commonly 
consumed vegetables by various ethnics in Malaysia [16]. 
The leaves were noted to be petiolate, elliptic-obovate, 
measuring 4 to 22 cm long and 2 to 15 cm broad, have a 
cuneate base with obtuse tip, reticulate venation, entire 
and smooth edges, a spiral arrangement and have a 
notable leathery texture [17]. When young, the leaves are 
pliable and reddish (Fig. 1), and when the leaves mature, 
they turn to dark green and leathery with prominent 
yellow veins (Fig. 2). 
As described earlier, the leaves of A. occidentale L. 
also possess an excellent source of bioactive compounds, 
including phenolic acids [8,18-19]. Alkali and water 
extracts of A. occidentale L. contained predominantly 
gallic acid as well as protocatechuic, p-hydroxybenzoic, 
cinnamic, p-coumaric, and ferulic acids [20]. Besides, 
flavonol glycosides were also identified from the extract 
of A. occidentale L. young leaves, with the highest 
constituent was kaempferol-3-O-glucoside, followed by 
kaempferol-3-O-arabinofuranoside and quercetin-3-O-
glucoside [16]. For this reason, this study sought to 
determine whether A. occidentale L. leaves extracts to 
play a role in the inhibition of α-amylase and DPPIV 
enzymes. 
In nature, the insoluble-bound phenolics are one 
of the components of cell walls, while soluble ester 
phenolics compartmentalized within the plant cell 
vacuoles [21]. Therefore, the yield of extraction 
depended on the polarity of the compound to the solvent 
and method of extraction [22]. In this study, the soluble 
ester and insoluble-bound phenolic fractions were 
undergone extraction with acid-alkali treatments to 
release them from the bonded form. Here, we compared 
the enzyme-inhibitory activities of the extracts between 
free, soluble esters, and insoluble-bound phenolic 
fractions, as well as between the young and mature 
leaves. It is anticipated that these findings could provide 
some possible mechanisms by which they are used in the 
management and prevention of type 2 diabetes mellitus. 
 
 
Fig 1. Young leaves of A. occidentale L. 
 
Fig 2. Mature leaves of A. occidentale L. 
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■ EXPERIMENTAL SECTION 
Materials 
All chemicals used in this study were analytical grade 
and purchased either from Merck or Fisher Scientific 
Chemicals (Germany). Ultrapure water was obtained from 
Mili- Q system and was used in HPLC and enzyme assays. 
The recombinant DPPIV (human) enzyme was purchased 
from Enzo Life Sciences (USA). DPPIV-Glo (TM) 
Protease assay was purchased from Promega. α-Amylase 
enzyme and sodium potassium tartrate tetrahydrate were 
purchased from Nacalai Tesque. Acarbose (95%) and  
3,5-dinitrosalicylic acid were purchased from Acros. 
Soluble starch, monosodium phosphate, disodium 
phosphate, and standards reference were purchased from 
Sigma Chemical Co. (Missouri, USA). Parts of young and 
mature leaves of A. occidentale L. (2.0 kg) were purchased 
from Taman Pertanian (Kuantan, Malaysia). 
Procedure 
Sample preparation for extraction 
Young and mature leaves of A. occidentale L. (2.0 kg) 
were selected and washed under running water for several 
times. The leaves were chopped into small pieces. The 
leaves were then put into a freezer bag and kept frozen at 
-20 °C for 24 h. The frozen leaves were freeze-dried with 
conditions of 63 Pa vacuum pressures at 30 °C for three 
days. Subsequently, the samples were ground and sieved 
to obtain a uniform size of fine powder (< 1 mm). The 
powdered samples were kept in a vacuum-sealed container 
and stored at -20 °C for further analysis. 
Sample extraction 
The fine powdered of A. occidentale L. young and 
mature leaves were extracted using the maceration method 
with three different phenolic fractions - free, soluble ester, 
and insoluble-bound phenolic fraction extracts. The 
samples were extracted using methanol according to the 
procedure described by Dvořáková et al. [23] and Singh et 
al. [24] with slight modifications. 
Free phenolic fraction. Three grams of powdered sample 
was extracted three times, with 30 mL of methanol (80%) 
on an ultrasonic bath at 60 °C for 1 h. The samples were 
centrifuged at 9000 ×g for 15 min at 4 °C. The supernatant 
was filtered using a no. 4 Whatman filter paper and 
evaporated until a semisolid residue was obtained using 
a Büchi rotary evaporator (Newcastle, DE). The semisolid 
residue was labeled as a crude extract. The crude extract 
was then extracted with diethyl ether (3 × 30 mL). The 
ether extracts were collected and evaporated to dryness 
using a Büchi rotary evaporator with 850 mbar at 35 °C. 
The dried sample was labeled as free phenolic and 
dissolved into two solvents, methanol, and DMSO. The 
free phenolic extract was stored at -20 °C for further 
analysis. The supernatant with esterified phenolic 
compounds was moved into a new Falcon tube. 
Soluble ester phenolic fraction. The supernatant with 
esterified phenolic compounds was treated with 20 mL 
of 4 M sodium hydroxide (NaOH) for 2 h at room 
temperature. The treated supernatant was then acidified 
to pH 2 by adding 6 M hydrochloride acid (HCl) and was 
extracted with diethyl ether (3 × 10 mL). The ether extract 
was collected and evaporated to dryness using a Büchi 
rotary evaporator with 850 mbar at 35 °C. The dried 
sample was labeled as soluble ester phenolic and dissolved 
into two solvents, methanol, and DMSO. Soluble ester 
phenolic extract was stored at -20 °C for further analysis. 
Insoluble-bound phenolic fraction. The residue 
obtained from free phenolic fraction extract was treated 
with 15 mL of 4 M sodium hydroxide (NaOH) for 1 h at 
room temperature. The treated residue was then acidified 
to pH 2 by adding 2 M hydrochloride acid (HCl) followed 
by centrifuged for 10 min at 5000 ×g. The layer of 
supernatant was collected and extracted with 15 mL of 
hexane to remove free fatty acid and other lipids 
contaminants. The liberated phenolic was extracted with 
diethyl ether (3 × 10 mL). The ether extracts were collected 
and evaporated to dryness using a Büchi rotary evaporator 
with 850 mbar at 35 °C. The dried sample was labeled as 
insoluble bound phenolic and dissolved into two 
solvents, methanol, and DMSO. The insoluble-bound 
phenolic extract was stored at -20 °C for further analysis. 
High-performance liquid chromatography (HPLC) 
analysis 
High-performance liquid chromatography 
(HPLC) analysis consists of HPLC equipped with an 
ultraviolet-visible (UV-Vis). Before injection, each 
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extracted sample was allowed to be filtered by a 0.45 µm 
PTFE filter (Millipore). The injection volume was 5 µL. A 
C-6 phenyl column (250 × 4.6 mm i.d., particle size 5 μm, 
C-6 Phenyl, phenomenex, Torrance, CA, USA) was used 
for the separation of sample components at 25 °C. For 
phenolic acid analysis, the mobile phase comprised of 
solvent A (methanol) and solvent B (a 1.5%, v/v, solution 
of formic acid in water). For flavonoids analysis, the 
mobile phase comprised of solvent A (methanol), solvent 
B (acetonitrile) and solvent C (0.5–1.0%, v/v, solution of 
formic acid in water). The flow rate was set at 1.0 mL/min 
for the compounds. 
In vitro α-amylase inhibition study 
α-Amylase enzyme activity was 3100 Unit/mg of 
protein (Nacalai Tesque). The α-Amylase enzyme was 
dissolved in sodium phosphate or phosphate buffer 
solution to give a concentration of 12 unit/mL solution. 
Soluble starch (1%, w/v) in water was used as a substrate 
solution. Briefly, 250 µL of extracted samples with DMSO 
were put into a screw-top Falcon tube. Then, 250 µL of the 
α-amylase enzyme in a phosphate buffer solution with pH 
6.9 was added into the Falcon tube. The mixture was 
preincubated for 10 min at 25 °C. Approximately 250 µL 
of the starch solution was mixed in the mixture as a 
substrate and incubated for another 10 min at 25 °C. Next, 
500 µL of DNS color reagent solution (96 mM  
3,5-dinitrosalicylic acid, 5.31 M sodium potassium 
tartrate in 2 M NaOH) was added into the Falcon tube to 
terminate the reaction. The Falcon tube was then placed 
into boiling water for 10 min. The mixture was cooled 
down and diluted with 5 mL of distilled water. 
The α-amylase activity was determined by 
measuring the absorbance of the mixture in a transparent 
96-well plate at 540 nm. Control incubations that 
represent 100% enzyme activity were conducted in an 
identical fashion replacing plant extract with DMSO. The 
absorbance (A) due to maltose generated was calculated 
using the following calculation: 
A 540 nm control or plant extract = A 540 nm Test – A 540 nm Blank   
The % of maltose generated was calculated from the 
linear equation obtained from the maltose standard 
calibration curve (0–0.25%, w/v, maltose). Percentage of 





ction = ×   
In vitro dipeptidyl peptidase IV (DPPIV) inhibition 
study 
The A. occidentale L. extracts were examined for 
inhibition bioactivities on DPPIV using the Promega 
DPPIV-Glo Protease Assay kit with a white 96-well 
plate. Before the inhibition test was performed, each 
sample was allowed to pass through a 0.45 µm PTFE 
filter (Millipore). The purified porcine DPPIV enzyme 
(88% homology to the human enzyme) from Sigma-
Aldrich was used to determine the activity of DPPIV 
inhibitor. DPPIV enzyme activity was defined as 1 Unit 
produces 1 µmol free pNA/min, using standard DPPIV 
assay condition at 37 °C. The DPPIV inhibitor activities 
were observed using a luminometer (Luminoskan 
Ascent 2.6) to detect luminescence on the white 96-well 
plate. IC50 values (µg/mL) were calculated from the 
quadratic formula generated from the log 
(concentration) and percentage inhibition. The 
protocols of analysis were based on the manufacturer 
specifications from Promega [25]. Kaempferol was used 
as a positive control. 
Statistical analysis 
Results were expressed as means ± SEM. The 
analysis was analyzed using SPSS statistical software 
(SPSS version 20; SPSS Inc., Chicago, IL). T-test analysis 
was used to compare the means between young and 
mature leaves. One-way analysis of variance (ANOVA) 
and Tukey’s Honestly Significant Difference test was 
used to compare means between fractions. The level of 
significance was set at p < 0.05, which corresponds to a 
95% confidence level. 
■ RESULTS AND DISCUSSION 
High-Performance Liquid Chromatography (HPLC) 
Analysis 
The presence of phenolic acid and flavonoids in A. 
occidentale L. leave extracts were first determined by 
HPLC using external standards. In this analysis, it was 
found that all extracts contained phenolic acid and 
flavonoids. Free phenolic fraction had a higher 
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concentration of phenolic acid but a lower concentration 
of flavonoids compared to soluble ester and insoluble-
bound phenolic fractions. Mature leaves of A. occidentale 
L. contained higher concentration in both phenolic acid 
and flavonoids than the young leaves. This trend was in 
line with a previous study where the presence of phenolic 
compounds varies in different parts of leaves. The 
variation of phenolic compounds concentration has also 
been reported at different stages of maturity of plants [26]. 
An in vitro Study of α-Amylase and DPPIV Inhibitory 
by Maturity 
Phenolic compounds in three different fractions 
between the young and mature leaves of A. occidentale L. 
were further analyzed for their α-amylase inhibitory effect 
(Table 1). Free phenolic fraction (72.45 ± 3.6%) in the 
mature leaves demonstrated a higher inhibition percentage 
of α-amylase activities than that in the young leaves (p < 
0.05). Similarly, soluble ester phenolic fraction (83.40 ± 
4.7%) in the mature leaves also exhibited a greater α-
amylase inhibitor as compared to the young leaves (p < 
0.001). However, the α-amylase inhibitory effect of the 
insoluble-bound phenolic fraction was not significantly 
different between the matured and young leaves. 
Table 2 shows the concentration of phenolic 
compounds fractions from the young and mature leaves 
of A. occidentale L. in the inhibition of DPPIV (IC50). IC50 
is defined as the concentration of an inhibitor (extracts of 
A. occidentale L. leaves) where the DPPIV enzyme activity 
is reduced by half (50%). A lower concentration indicates 
a more potent inhibitor. Regardless of fractions, the 
mature leaves were generally more effective in reducing 
the activity of DPPIV than the young leaves. Specifically, 
soluble ester (4.09 ± 0.34 µg/mL) and insoluble-bound 
(4.87 ± 0.32 µg/mL) phenolic fractions of the mature 
leaves were found to be significantly more potent 
inhibitors of DPPIV activities than the young leaves (p < 
0.001). Nevertheless, no statistical difference was found 
between the mature and young leaves for the DPPIV 
inhibition activity by a free phenolic fraction. 
In summary, it is clear that the mature leaves of A. 
occidentale L. are more potent inhibitors of both α-amylase  
Table 1. The inhibition percentage of α-amylase 
activities in the presence of compounds extracted (0.6 
mg/mL) from A. occidentale L. Results are expressed in 
means ± SEM 
Fractiona Young (%) Mature (%) 
Free 54.92 ± 2.3 72.45 ± 3.6b 
Soluble ester 16.34 ± 1.5 83.40 ± 4.7c 
Insoluble-bound 69.04 ± 2.8 69.65 ± 1.9 
aFraction of phenolic compounds extracted from A. occidentale 
L. was used in the α-amylase inhibition study; bYoung and 
mature leaves were compared by t-test, p-value < 0.05; cYoung 
and mature leaves were compared by t-test, p-value < 0.001 
Table 2. DPPIV inhibition activity for free, soluble ester 
and insoluble-bound phenolic compounds are tabulated 
by concentration (IC50) = µg/mL. Results are expressed 
in means ± SEM 
Fractionsa Young Mature 
Free 156.6 ± 27.5 53.46 ± 6.49 
Soluble ester 8.29 ± 0.33 4.09 ± 0.34b 
Insoluble-bound 11.48 ± 0.48 4.87 ± 0.32b 
aFractions of phenolic compounds extracted from A. occidentale 
L. were used in the DPPIV inhibition study; bYoung and mature 
leaves were compared by t-test, p-value < 0.001 
and DPPIV enzyme activities than the young leaves. Of 
relevance, our previous study had found that the 
concentration of phenolic acid and flavonoids were 
higher in A. occidentale L. mature leaves than in the 
young leaves (unpublished data). Therefore, it is 
believed that the higher phenolic content may 
proportionately increase its antioxidant capacity toward 
inhibiting both enzyme activity [12]. 
An in vitro α-Amylase and DPPIV Inhibitory 
Activity Study by Fractions 
Fig. 3 shows the comparison between the free, 
soluble ester and insoluble-bound phenolic fractions in 
inhibiting α-amylase activity in the young and mature 
leaves, respectively. In the young leaf extracts, the 
insoluble- bound phenolic fraction (69.04 ± 2.8%) 
demonstrated a significantly more potent inhibitor than 
free (54.92 ± 2.3%, p < 0.05) and soluble ester phenolic 
fractions (16.34 ± 1.5%, p < 0.0001). Likewise, free  
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Fig 3. Comparison within phenolic fractions in inhibiting 
α-amylase activities using one-way ANOVA followed by 
Tukey’s multiple comparison test analysis. Results are 
expressed in means ± SEM. *p < 0.05 and ****p < 0.0001 
phenolic had a greater capability in inhibiting α-amylase 
enzyme than soluble ester phenolic fraction (p < 0.0001). 
On the contrary, we found no significant differences in 
the α-amylase inhibitory effect between fractions of the 
mature leaves’ extracts. 
Fig. 4 indicates that in young leaf extracts, soluble 
ester (8.29 ± 0.33) and insoluble-bound (11.48 ± 0.48) 
phenolic fractions demonstrated a stronger inhibitor of 
DPPIV than free phenolic (156.6 ± 27.5, p < 0.001). A 
similar trend for the mature leaves extracts was noted 
where soluble ester (4.09 ± 0.34) and insoluble-bound 
(4.87 ± 0.32) phenolic fractions also exhibited a lower IC50 
than free phenolic (53.46 ± 6.49, p < 0.001). No significant 
differences were found between the soluble ester and 
insoluble-bound phenolic fractions for both the young 
and mature leaves, respectively. 
It appears that insoluble-bound fraction was the most 
potent inhibitor when compared to free and soluble ester 
phenolic fraction in both α-amylase and DPPIV inhibition 
activities. Although soluble ester phenolic fraction did not 
strongly inhibit the α-amylase activity, it was nevertheless 
effective in inhibiting DPPIV activity. We speculate that 
soluble ester and insoluble-bound phenolic fractions may 
contain a higher concentration of flavonoids than the free 
phenolic fraction. As indicated by a previous study, 
flavonoids were a strong inhibitor of α-amylase and DPPIV 
 
Fig 4. Comparison within phenolic fractions in DPPIV 
inhibition activities using one-way ANOVA followed by 
Tukey’s multiple comparison test analysis. Results are 
expressed in means ± SEM, ***p < 0.001 
enzymes [27]. In another study, it was shown that the 
soluble ester and insoluble-bound phenolic extracts of 
Moringa oleifera seed flour were more effective with 
minimum inhibitory concentration against bacteria 
than free phenolic fractions [24]. 
■ CONCLUSION 
Our findings indicated that the mature leaves of A. 
occidentale L. possessed better antidiabetic properties, as 
shown by a greater inhibition of both α-amylase and 
DPPIV enzymes when compared to young leaves. It was 
also observed that regardless of the maturity of the 
leaves, soluble ester and insoluble-bound phenolic 
fractions were a more potent inhibitor of α-amylase and 
DPPIV enzymes than free phenolic. Further studies of 
the elucidation and characterization methodologies are 
required in identifying specific phenolic compounds 
that are responsible for the inhibition of these enzymes. 
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